论文信息 - Microfluidic cell squeeze-based vaccine comes into clinical investigation - 字舞流文

Microfluidic cell squeeze-based vaccine comes into clinical investigation

Shuhang Wang | Ning Li | Yuqi Yang | Yan Zha

[1] K. Jensen,et al. Microfluidic Squeezing Enables MHC Class I Antigen Presentation by Diverse Immune Cells to Elicit CD8+ T Cell Responses with Antitumor Activity , 2022, The Journal of Immunology.

[2] Pallavi Gupta,et al. Microfluidic mechanoporation for cellular delivery and analysis , 2021, Materials today. Bio.

[3] A. Jimeno,et al. 48MO SQZ-PBMC-HPV-101: Preliminary results of a first-in-human, dose-escalation study of a cell-based vaccine in HLA A*02+ patients with recurrent, locally advanced, or metastatic HPV16+ solid tumors , 2021, Annals of Oncology.

[4] James C. Weaver,et al. High-throughput Nuclear Delivery and Rapid Expression of DNA via Mechanical and Electrical Cell-Membrane Disruption , 2017, Nature Biomedical Engineering.

[5] K. Jensen,et al. In vitro and ex vivo strategies for intracellular delivery , 2016, Nature.

[6] Robert Langer,et al. Cell squeezing as a robust, microfluidic intracellular delivery platform. , 2013, Journal of visualized experiments : JoVE.

[7] Robert Langer,et al. A vector-free microfluidic platform for intracellular delivery , 2013, Proceedings of the National Academy of Sciences.

[8] J. Saiz,et al. Right‐sided non‐recurrent laryngeal nerve without any vascular anomaly: an anatomical trap , 2021, ANZ journal of surgery.